Clinical Trials Directory

Trials / Completed

CompletedNCT00051155

A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT)

A 6-Week Safety and Efficacy Study of TRAVATAN Compared to XALCOM in Subjects With Open-Angle Glaucoma or Ocular Hypertension.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
—
Sponsor
Alcon Research · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To compare the safety and IOP-lowering efficacy of TRAVATAN and XALCOM in subjects with open-angle glaucoma or ocular hypertension.

Conditions

Interventions

TypeNameDescription
DRUGTravoprost (0.004%)
DRUGLatanoprost (0.005%)/Timolol (0.5%)

Timeline

Start date
2001-01-01
Primary completion
2004-07-01
Completion
2004-07-01
First posted
2003-01-07
Last updated
2008-08-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00051155. Inclusion in this directory is not an endorsement.